The field of microfluidics has applications in areas such as biomedical research, diagnostics, drug delivery, cell biology, chemistry, and environmental monitoring. Image credit: AI Asset Generator via Shutterstock.

3D printing specialist Microlight3D and deep-tech company Eden Tech are collaborating to advance the development of microfluidic equipment for healthcare researchers and developers.

Under the team-up, the French companies will combine Microlight3D’s Smart Print UV lithograph for producing 2D shapes at micron resolution with Eden Tech’s FLUI’DEVICE platform for developing microfluidic devices. The combined technologies are expected to help researchers more rapidly create prototypes for microfluidic equipment such as moulds, devices, and structures.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

According to the companies, their combined technologies will support healthcare researchers in creating complex designs with the “unmatched accuracy required” in the development of microfluidics used in diagnostic tools, lab-on-a-chip devices, and research apparatus.

Eden Tech sales head Victor Morel commented: “We believe that this partnership will set a new benchmark in the field of microfluidics.

“With healthcare systems and research laboratories increasingly seeking efficient and reliable microfluidic devices, the demand for solutions that integrate precision, scalability and cost-effectiveness has never been greater.”

The combined technology provisions are also expected to result in faster and more efficient workflows compared to computer-aided design (CAD) printing software. In addition, the ability to export microfluidic designs created with the combined technologies into various formats to ensure compatibility with production systems is expected to cut down on manufacturing errors.

Microlight3D founder Denis Barbier said the partnership allows the company to offer a solution for creating microfluidic designs compatible with the formats used by its machines.

“This will enable our users to integrate this tool into their current workflow, while streamlining the steps involved,” said Barbier.

Elsewhere in the field of microfluidics, Parallel Fluidics secured $7m in seed funding last year to develop a custom manufacturing platform for microfluidic devices.